Reglan Tablet
NDC Package 62559-166-01
Package Information
Reglan (metoclopramide hydrochloride) tablets is a medication used to treat certain conditions of the stomach and intestines. This formulation utilizes a tablet delivery system. Marketed by Ani Pharmaceuticals, Inc., this product is identified by NDC 62559-166 and is authorized under FDA application NDA017854.
Identification & Billing
- RxCUI: 207265 - reglan 5 MG Oral Tablet
- RxCUI: 207265 - metoclopramide 5 MG Oral Tablet [Reglan]
- RxCUI: 207265 - Reglan (as the monohydrochloride monohydrate) 5 MG Oral Tablet
- RxCUI: 207265 - Reglan 5 MG Oral Tablet
- RxCUI: 207266 - reglan 10 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 62559 - Ani Pharmaceuticals, Inc.
- 62559-166 - Reglan
- 62559-166-01 - 100 TABLET in 1 BOTTLE, PLASTIC
- 62559-166 - Reglan
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 62559-166-01 identifies a specific commercial package of 100 tablet in 1 bottle, plastic of Reglan, a human prescription drug labeled by Ani Pharmaceuticals, Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 100 billable units per package. This tablet is formulated for oral use and contains metoclopramide hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Ani Pharmaceuticals, Inc. on July 05, 2011. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
This medication is used to treat certain conditions of the stomach and intestines. Metoclopramide is used as a short-term treatment (4 to 12 weeks) for persistent heartburn when the usual medicines do not work well enough. It is used mostly for heartburn that occurs after a meal or during the daytime. Treating persistent heartburn can decrease the damage done by stomach acid to the swallowing tube (esophagus) and help healing. Metoclopramide is also used in diabetic patients who have poor emptying of their stomachs (gastroparesis). Treating gastroparesis can decrease symptoms of nausea, vomiting, and stomach/abdominal fullness. Metoclopramide works by blocking a natural substance (dopamine). It speeds up stomach emptying and movement of the upper intestines. This drug is not recommended for use in children due to an increased risk of serious side effects (such as muscle spasms/uncontrolled muscle movements). Ask the doctor or pharmacist for details.
How is this Ani Pharmaceuticals, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 62559016601. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.